Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

YTHDF3 mediates HNF1α regulation of cervical cancer radio‐resistance by promoting RAD51D translation in an m6A‐dependent manner
Hui Du, Nai‐Yi Zou, Hong‐Ling Zuo, et al.
FEBS Journal (2022) Vol. 290, Iss. 7, pp. 1920-1935
Closed Access | Times Cited: 20

Showing 20 citing articles:

The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
Zhonghao Mao, Bingyu Wang, Teng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 22
The research progress on radiation resistance of cervical cancer
Мейли Лианг, Liying Sheng, Yumin Ke, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 6
Regulation of m6A modification on ferroptosis and its potential significance in radiosensitization
Xun Chen, Lejia Zhang, Yi He, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 14
Targeting RNA modifications with pharmacological agents: New frontiers in cancer therapy
Angel Guan, Justin Wong
Cancer Medicine (2024) Vol. 13, Iss. 7
Open Access | Times Cited: 4
Decoding intricate interactions between m6A modification with mRNAs and non-coding RNAs in cervical cancer: Molecular mechanisms and clinical implications
Xuefei Liu, Lizhi Zhang, Ji Chen, et al.
Cellular Signalling (2025), pp. 111745-111745
Closed Access
YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylation
Rongfang Gong, Z. H. Zhang, Tung‐Tien Sun, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 3
ZC3H13 Enhances the Malignancy of Cervical Cancer by Regulating m6A Modification of CKAP2
Yuan Zhang, Xiaohong Chen, Huiqun Chen, et al.
Critical Reviews in Immunology (2023) Vol. 43, Iss. 6, pp. 1-13
Closed Access | Times Cited: 8
Examining the evidence for mutual modulation between m6A modification and circular RNAs: current knowledge and future prospects
Xiaozhu Tang, Mengjie Guo, Yuanjiao Zhang, et al.
Journal of Experimental & Clinical Cancer Research (2024) Vol. 43, Iss. 1
Open Access | Times Cited: 2
Epitranscriptomics and cervical cancer: the emerging role of m6A, m5C and m1A RNA modifications
Akshat D. Modi, Hira Zahid, Ashlyn Chase Southerland, et al.
Expert Reviews in Molecular Medicine (2024) Vol. 26
Closed Access | Times Cited: 2
N6-Methyladenosine-Modified LEAWBIH Drives Hepatocellular Carcinoma Progression through Epigenetically Activating Wnt/β-Catenin Signaling
Huamei Wei, Lizheng Huang, Qi Lu, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1991-2007
Open Access | Times Cited: 6
RNA methylation, homologous recombination repair and therapeutic resistance
Yu Bai, Hanlin Zhao, Haijun Liu, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 166, pp. 115409-115409
Open Access | Times Cited: 4
Overexpression of YTHDF3 increases the specific productivity of the recombinant protein in CHO cells by promoting the translation process
Zhao‐ming Cui, Yingying Feng, Yan‐ping Gao, et al.
Biotechnology Journal (2024) Vol. 19, Iss. 4
Closed Access | Times Cited: 1
m6A modification of RNA in cervical cancer: role and clinical perspectives
Yajuan Gao, Qi Guo, L.‐C. Yu
RNA Biology (2024) Vol. 21, Iss. 1, pp. 49-61
Open Access | Times Cited: 1
METTL3 facilitates the progression of cervical cancer by m6A modification-mediated up-regulation of NEK2
Yilin Guo, Yangyang Bai, Lu Wang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Epitranscriptomic RNA m6A Modification in Cancer Therapy Resistance: Challenges and Unrealized Opportunities
Mohammad B. Uddin, Zhishan Wang, Chengfeng Yang
Advanced Science (2024)
Open Access | Times Cited: 1
YTHDF3 modulates the Cbln1 level by recruiting BTG2 and is implicated in the impaired cognition of prenatal hypoxia offspring
Likui Lu, Yajun Shi, Bin Wei, et al.
iScience (2023) Vol. 27, Iss. 1, pp. 108703-108703
Open Access | Times Cited: 3
The therapeutic targets of N6-methyladenosine (m6A) modifications on tumor radioresistance
Yi Zhang, Wendong Gu, Yingjie Shao
Discover Oncology (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 2
A comprehensive review of m 6 A research in cervical cancer
Jing Hu, Shizhi Wang, Xiuting Li
Epigenomics (2024) Vol. 16, Iss. 10, pp. 753-773
Closed Access
RNA m6A methylation and MDSCs: Roles and therapeutic implications for radiotherapy
Liangliang Wang, Rohan R. Katipally, Hua Liang, et al.
Med (2023) Vol. 4, Iss. 12, pp. 863-874
Open Access | Times Cited: 1
YTHDF3 modulates the progression of breast cancer cells by regulating FGF2 through m6A methylation
RF Gong, ZH Zhang, Ting Sun, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Page 1

Scroll to top